Pacific Software Inc. Secures Strategic License Agreement with the University of California for Innovative Technology for Stimulating Collagen Production
May 15, 2024 09:00 ET
|
Pacific Software Inc.
Pacific Software Inc. partners with UCI to launch Dermatrix™, a revolutionary collagen-boosting peptide for cosmetics and wound healing.
Rejuvine Life Sciences Launches Crowdfunding Campaign to Revolutionize Diabetes Management with Science-Backed, Natural Solutions
May 14, 2024 06:00 ET
|
Rejuvine Life Sciences Inc.
MIDDLETOWN, Del., May 14, 2024 (GLOBE NEWSWIRE) -- via IBN -- Rejuvine Life Sciences, dedicated to developing natural healthcare solutions, today announces a crowdfunding campaign to expand their...
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for implantable pump delivery
May 09, 2024 07:00 ET
|
Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or the “Company”) ARECOR AND MEDTRONIC DIABETES ESTABLISH COLLABORATION TO DEVELOP A NOVEL THERMOSTABLE INSULIN FOR IMPLANTABLE PUMP DELIVERY Medtronic to fund...
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
May 08, 2024 06:00 ET
|
Fractyl Health, Inc.
Fractyl Health to Present at BofA Securities 2024 Health Care Conference
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
May 06, 2024 07:15 ET
|
SAB Biotherapeutics, Inc.
MIAMI, May 06, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS) (the “Company” or “SAB”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform developing a human...
Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B
May 02, 2024 08:00 ET
|
Intuity Medical
FREMONT, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that its POGO Automatic®...
Discovery Therapeutics Caribe Receives Study May Proceed Letter from FDA to initiate a Phase 3 Clinical Trial of intralesional rhEGF for the treatment of diabetic foot ulcers
April 30, 2024 09:00 ET
|
Discovery Therapeutics Caribe, LLC
FDA approves Discovery Therapeutic Caribe's Phase 3 trial for intralesional rhEGF in severe diabetic foot ulcers.
Fractyl Health Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
April 30, 2024 08:38 ET
|
Fractyl Health, Inc.
Fractyl Health Announces Multiple Presentations at DDW 2024 Conference and the German Diabetes Association (DDG) Annual Meeting
Global Drug Infusion System Market Size Grows Steadily at a CAGR of 6.9%: Straits Research
April 29, 2024 10:05 ET
|
Straits Research Private Limited - Reed Intelligence
New York, United States, April 29, 2024 (GLOBE NEWSWIRE) -- A drug infusion system is a medical device that allows fluids, medicines, and therapeutic substances to be administered directly into a...
LiveCare Inc. (OTCMKTS: LVCE) Marks Monumental Revenue Milestone Setting Eyes on Profitability
April 11, 2024 09:00 ET
|
LiveCare Inc.
Venice, FL, April 11, 2024 (GLOBE NEWSWIRE) -- LiveCare Inc. (OTCMKTS: LVCE), a pioneering force in the telehealth sector, proudly announces a significant financial milestone, having surpassed...